MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Cancer Profiling Market Research Report: Forecast (2024–2030). This report provides a detailed assessment of the Cancer Profiling, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.
Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.
Market Timeline Overview
- Historical Years: 2019–22
- Base Year: 2023
- Forecast Years: 2024–30
This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.
Download a FREE PDF Sample of the Report: - https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html (Discover the market potential, platform-specific insights, and key industry trends.)
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Cancer Profiling Market Outlook
The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30. The major factors responsible for the market growth include; the rising prevalence of cancer, increasing research on cancer therapies, and the launch of improved technologies for tumor profiling among others. There has been an increase in the number of cancer cases globally, especially across the US, India, etc., as stated by various healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, the Global Cancer Observatory, etc.
Cancer Profiling Market Drivers:
Rising Adoption of Precision Medicine Augmenting Market Growth – Personalized medicines are treatments that are tailored to a patient's unique genetic, environmental, and lifestyle characteristics to deliver targeted & precise therapies. The consumers' growing awareness of personalized medicine's superior efficacy to conventional medicine for cancer treatment has been driving their demand, especially across countries the US, India, the UK, etc.
View Full Report (All Data, In One Place): - https://www.marknteladvisors.com/research-library/cancer-profiling-market.html (Explore in-depth analyses, technological trends, and investment patterns.)
Cancer Profiling Market Trends:
Introduction of Single Cell Genomics Technique Fueled the Market Growth – The introduction of advanced kits and instruments for the identification of single-cell profiling revolutionized the cancer profiling services market in recent years. The single-cell profiling technologies allow the user to identify a complete study of a single cell, in contrast to providing an average measurement of genomic and proteomic information obtained from traditional techniques.
Cancer Profiling Market Segmentation
The study categorizes the Cancer Profiling into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.
By Type of Cancer
- Breast Cancer - Market Size & Forecast 2019-2030, USD Million
- Colorectal Cancer - Market Size & Forecast 2019-2030, USD Million
- Gynecological Cancer - Market Size & Forecast 2019-2030, USD Million
- Leukemia - Market Size & Forecast 2019-2030, USD Million
- Prostate Cancer - Market Size & Forecast 2019-2030, USD Million
- Lung Cancer - Market Size & Forecast 2019-2030, USD Million
- Others (Pancreatic Cancer, Skin Cancer, etc.) - Market Size & Forecast 2019-2030, USD Million
By Technology
- Next-Generation Sequencing - Market Size & Forecast 2019-2030, USD Million
- Polymerase Chain Reaction - Market Size & Forecast 2019-2030, USD Million
- Mass Spectrometry - Market Size & Forecast 2019-2030, USD Million
- In-Situ Hybridization - Market Size & Forecast 2019-2030, USD Million
- Microarrays Analysis - Market Size & Forecast 2019-2030, USD Million
- Others (Single-Cell Sequencing, etc.) - Market Size & Forecast 2019-2030, USD Million
By Biomarker Type
- Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
- Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
- Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million
By Cell Type
- Germline - Market Size & Forecast 2019-2030, USD Million
- Somatic - Market Size & Forecast 2019-2030, USD Million
By Application
- Oncology Research - Market Size & Forecast 2019-2030, USD Million
- Precision Medicine - Market Size & Forecast 2019-2030, USD Million
- Clinical Diagnostics - Market Size & Forecast 2019-2030, USD Million
- Others (Prognosis, Monitoring and Recurrence Detection, etc.) - Market Size & Forecast 2019-2030, USD Million
By End-User
- Hospitals and Clinics - Market Size & Forecast 2019-2030, USD Million
- Research Institutions and Laboratories - Market Size & Forecast 2019-2030, USD Million
- Diagnostic Service Providers - Market Size & Forecast 2019-2030, USD Million
- Pharmaceutical and Biotechnology Companies - Market Size & Forecast 2019-2030, USD Million
Geographical Analysis
The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia Pacific.
Talk to Our Industry Analyst: - https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-profiling-market.html Get personalized insights into company strategies and regional market dynamics.)
Leading Companies in Cancer Profiling Market Worldwide: Players, Analysis & Future Outlook
- NeoGenomics Laboratories
- Eurofins Genomics GmbH
- Hoffmann-La Roche Ltd (Foundation Medicine)
- OncoDNA SA
- 10x Genomics, Inc.
- Caris Life Sciences.
- Geneseeq Technology Inc.
- Genetron Holdings Limited
- Laboratory Corporation of America Holdings (LabCorp)
- Dante Labs Inc.
- Celemics, Inc.
- Strand Life Sciences
- Myriad Genetics, Inc.
- QIAGEN GmbH
- Tempus Labs
Key Highlights of the Report
- Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2024 to 2030.
- Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
- Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
- Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.
Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences
Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/cancer-profiling-market.html
Frequently Asked Questions (FAQ)
- What is the projected growth rate of the Cancer Profiling?
2. What are the major factors driving this market’s growth?
3. Which regions are expected to lead the Cancer Profiling?
4. Who are the prominent players in the Cancer Profiling?
5. How is the competition structured in this market?
6. How can I access the full report?
About Us
MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.
Contact Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com